
National Research Corporation NRC
$ 15.88
-5.7%
Annual report 2025
added 03-05-2026
National Research Corporation PEG Ratio 2011-2026 | NRC
Annual PEG Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.14 | -7.26 | 5.85 | 8.14 | 3.79 | 4.13 | 2.6 | 0.354 | 3.84 | 1.22 | -4.57 | -0.588 | -0.34 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.14 | -7.26 | 0.771 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
0.283 | $ 16.65 | - | $ 179 M | ||
|
Agilent Technologies
A
|
2.05 | $ 113.98 | -0.78 % | $ 34.6 B | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.0363 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 24.15 | -2.23 % | $ 671 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 1.61 | -1.21 % | $ 2.14 M | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 22.01 | 0.43 % | $ 1.17 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 15.24 | -0.39 % | $ 461 M | ||
|
Illumina
ILMN
|
2.16 | $ 125.07 | -1.46 % | $ 19.9 B | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 167.08 | 0.22 % | $ 8.28 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
-3.43 | $ 82.63 | -0.59 % | $ 10.4 B | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 82.9 | -0.78 % | $ 5.59 B | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 1.93 | - | $ 8.54 M | ||
|
Koninklijke Philips N.V.
PHG
|
-0.461 | $ 25.77 | -5.03 % | $ 20 B | ||
|
Personalis
PSNL
|
-2.42 | $ 5.34 | -2.92 % | $ 316 M | ||
|
Senseonics Holdings
SENS
|
0.098 | $ 7.03 | -2.09 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 403.62 | -1.5 % | $ 11.6 B | ||
|
Biomerica
BMRA
|
-0.0105 | $ 2.18 | -0.46 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 111.86 | 9.14 % | $ 9.23 B | ||
|
Laboratory Corporation of America Holdings
LH
|
22.7 | $ 260.29 | 0.29 % | $ 21.7 B | ||
|
Trinity Biotech plc
TRIB
|
-0.637 | $ 0.61 | -0.23 % | $ 61.9 M | ||
|
NeoGenomics
NEO
|
0.0904 | $ 9.6 | 6.43 % | $ 1.23 B | ||
|
Twist Bioscience Corporation
TWST
|
-2.4 | $ 57.42 | -2.92 % | $ 3.43 B | ||
|
Celcuity
CELC
|
-0.769 | $ 118.83 | -1.04 % | $ 5.56 B | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 9.19 | -1.61 % | $ 1.99 B | ||
|
Myriad Genetics
MYGN
|
-0.00983 | $ 4.77 | -1.45 % | $ 442 M | ||
|
Natera
NTRA
|
-0.401 | $ 196.02 | -2.08 % | $ 19.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 192.19 | -1.43 % | $ 21.3 B | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | ||
|
Exagen
XGN
|
1.93 | $ 2.68 | -1.83 % | $ 57.8 M | ||
|
OpGen
OPGN
|
0.00227 | - | -16.95 % | $ 1.54 M |